Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 266 entries
Sorted by: Best Match Show Resources per page
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience.

Cancers

Vitiello PP, De Falco V, Giunta EF, Ciardiello D, Cardone C, Vitale P, Zanaletti N, Borrelli C, Poliero L, Terminiello M, Arrichiello G, Caputo V, Famiglietti V, Mattera Iacono V, Marrone F, Di Liello A, Martini G, Napolitano S, Caraglia M, Lombardi A, Franco R, De Vita F, Morgillo F, Troiani T, Ciardiello F, Martinelli E.
PMID: 31597339
Cancers (Basel). 2019 Oct 08;11(10). doi: 10.3390/cancers11101504.

Tumor heterogeneity represents a possible cause of error in detecting predictive genetic alterations on tumor tissue and can be overcome by testing alterations in circulating tumor DNA (ctDNA) using liquid biopsy. We assessed 72 consecutive patients with a diagnosis...

Cite
Vitiello PP, De Falco V, Giunta EF, et al. Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience. Cancers (Basel). 2019;11(10)doi: 10.3390/cancers11101504.
Vitiello, P. P., De Falco, V., Giunta, E. F., Ciardiello, D., Cardone, C., Vitale, P., Zanaletti, N., Borrelli, C., Poliero, L., Terminiello, M., Arrichiello, G., Caputo, V., Famiglietti, V., Mattera Iacono, V., Marrone, F., Di Liello, A., Martini, G., Napolitano, S., Caraglia, M., Lombardi, A., Franco, R., De Vita, F., Morgillo, F., Troiani, T., Ciardiello, F., & Martinelli, E. (2019). Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience. Cancers, 11(10), . https://doi.org/10.3390/cancers11101504
Vitiello, Pietro Paolo, et al. "Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience." Cancers vol. 11,10 (2019). doi: https://doi.org/10.3390/cancers11101504
Vitiello PP, De Falco V, Giunta EF, Ciardiello D, Cardone C, Vitale P, Zanaletti N, Borrelli C, Poliero L, Terminiello M, Arrichiello G, Caputo V, Famiglietti V, Mattera Iacono V, Marrone F, Di Liello A, Martini G, Napolitano S, Caraglia M, Lombardi A, Franco R, De Vita F, Morgillo F, Troiani T, Ciardiello F, Martinelli E. Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience. Cancers (Basel). 2019 Oct 08;11(10). doi: 10.3390/cancers11101504. PMID: 31597339; PMCID: PMC6827157.
Copy Download .nbib Format: NLM
Corrigendum to "Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation" [Arch Med Res 2018; 49: 198-204].

Archives of medical research

Feola M, Testa M, Ferreri C, Cardone M, Sola M, Ariotti S, LucaRosso G.
PMID: 30554859
Arch Med Res. 2020 Feb;51(2):185. doi: 10.1016/j.arcmed.2018.12.001. Epub 2018 Dec 13.

No abstract available.

Cite
Feola M, Testa M, Ferreri C, et al. Corrigendum to "Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation" [Arch Med Res 2018; 49: 198-204]. Arch Med Res. 2018;51(2):185doi: 10.1016/j.arcmed.2018.12.001.
Feola, M., Testa, M., Ferreri, C., Cardone, M., Sola, M., Ariotti, S., & LucaRosso, G. (2020). Corrigendum to "Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation" [Arch Med Res 2018; 49: 198-204]. Archives of medical research, 51(2), 185. https://doi.org/10.1016/j.arcmed.2018.12.001
Feola, Mauro, et al. "Corrigendum to "Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation" [Arch Med Res 2018; 49: 198-204]." Archives of medical research vol. 51,2 (2020): 185. doi: https://doi.org/10.1016/j.arcmed.2018.12.001
Feola M, Testa M, Ferreri C, Cardone M, Sola M, Ariotti S, LucaRosso G. Corrigendum to "Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation" [Arch Med Res 2018; 49: 198-204]. Arch Med Res. 2020 Feb;51(2):185. doi: 10.1016/j.arcmed.2018.12.001. Epub 2018 Dec 13. PMID: 30554859.
Copy Download .nbib Format: NLM
Prediction of state anxiety by machine learning applied to photoplethysmography data.

PeerJ

Perpetuini D, Chiarelli AM, Cardone D, Filippini C, Rinella S, Massimino S, Bianco F, Bucciarelli V, Vinciguerra V, Fallica P, Perciavalle V, Gallina S, Conoci S, Merla A.
PMID: 33520434
PeerJ. 2021 Jan 15;9:e10448. doi: 10.7717/peerj.10448. eCollection 2021.

BACKGROUND: As the human behavior is influenced by both cognition and emotion, affective computing plays a central role in human-machine interaction. Algorithms for emotions recognition are usually based on behavioral analysis or on physiological measurements (e.g., heart rate, blood...

Cite
Perpetuini D, Chiarelli AM, Cardone D, et al. Prediction of state anxiety by machine learning applied to photoplethysmography data. PeerJ. 2021;9:e10448doi: 10.7717/peerj.10448.
Perpetuini, D., Chiarelli, A. M., Cardone, D., Filippini, C., Rinella, S., Massimino, S., Bianco, F., Bucciarelli, V., Vinciguerra, V., Fallica, P., Perciavalle, V., Gallina, S., Conoci, S., & Merla, A. (2021). Prediction of state anxiety by machine learning applied to photoplethysmography data. PeerJ, 9e10448. https://doi.org/10.7717/peerj.10448
Perpetuini, David, et al. "Prediction of state anxiety by machine learning applied to photoplethysmography data." PeerJ vol. 9 (2021): e10448. doi: https://doi.org/10.7717/peerj.10448
Perpetuini D, Chiarelli AM, Cardone D, Filippini C, Rinella S, Massimino S, Bianco F, Bucciarelli V, Vinciguerra V, Fallica P, Perciavalle V, Gallina S, Conoci S, Merla A. Prediction of state anxiety by machine learning applied to photoplethysmography data. PeerJ. 2021 Jan 15;9:e10448. doi: 10.7717/peerj.10448. eCollection 2021. PMID: 33520434; PMCID: PMC7812926.
Copy Download .nbib Format: NLM
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.

The Lancet. Respiratory medicine

Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M.
PMID: 34597534
Lancet Respir Med. 2022 Jan;10(1):11-25. doi: 10.1016/S2213-2600(21)00322-2. Epub 2021 Sep 28.

BACKGROUND: Clinical trials have shown treatment benefits of dupilumab in patients with uncontrolled asthma for up to 1 year. This study aimed to evaluate the long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma, as data for...

Cite
Wechsler ME, Ford LB, Maspero JF, et al. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2021;10(1):11-25doi: 10.1016/S2213-2600(21)00322-2.
Wechsler, M. E., Ford, L. B., Maspero, J. F., Pavord, I. D., Papi, A., Bourdin, A., Watz, H., Castro, M., Nenasheva, N. M., Tohda, Y., Langton, D., Cardona, G., Domingo, C., Park, H. S., Chapman, K. R., Mao, X., Zhang, Y., Khan, A. H., Deniz, Y., Rowe, P. J., Kapoor, U., Khokhar, F. A., Mannent, L. P., Ruddy, M., Laws, E., Amin, N., & Hardin, M. (2022). Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. The Lancet. Respiratory medicine, 10(1), 11-25. https://doi.org/10.1016/S2213-2600(21)00322-2
Wechsler, Michael E, et al. "Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study." The Lancet. Respiratory medicine vol. 10,1 (2022): 11-25. doi: https://doi.org/10.1016/S2213-2600(21)00322-2
Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2022 Jan;10(1):11-25. doi: 10.1016/S2213-2600(21)00322-2. Epub 2021 Sep 28. PMID: 34597534.
Copy Download .nbib Format: NLM
Altered Bone Status in Rett Syndrome.

Life (Basel, Switzerland)

Pecorelli A, Cordone V, Schiavone ML, Caffarelli C, Cervellati C, Cerbone G, Gonnelli S, Hayek J, Valacchi G.
PMID: 34205017
Life (Basel). 2021 Jun 03;11(6). doi: 10.3390/life11060521.

Rett syndrome (RTT) is a monogenic neurodevelopmental disorder primarily caused by mutations in X-linked

Cite
Pecorelli A, Cordone V, Schiavone ML, et al. Altered Bone Status in Rett Syndrome. Life (Basel). 2021;11(6)doi: 10.3390/life11060521.
Pecorelli, A., Cordone, V., Schiavone, M. L., Caffarelli, C., Cervellati, C., Cerbone, G., Gonnelli, S., Hayek, J., & Valacchi, G. (2021). Altered Bone Status in Rett Syndrome. Life (Basel, Switzerland), 11(6), . https://doi.org/10.3390/life11060521
Pecorelli, Alessandra, et al. "Altered Bone Status in Rett Syndrome." Life (Basel, Switzerland) vol. 11,6 (2021). doi: https://doi.org/10.3390/life11060521
Pecorelli A, Cordone V, Schiavone ML, Caffarelli C, Cervellati C, Cerbone G, Gonnelli S, Hayek J, Valacchi G. Altered Bone Status in Rett Syndrome. Life (Basel). 2021 Jun 03;11(6). doi: 10.3390/life11060521. PMID: 34205017; PMCID: PMC8230033.
Copy Download .nbib Format: NLM
[Pericarditis por SARS-CoV-2: informe de caso].

Archivos de cardiologia de Mexico

Tufo-Pereyra A, Scatularo CE, Cardone F, Grancelli H.
PMID: 34077413
Arch Cardiol Mex. 2021 Jun 02; doi: 10.24875/ACM.21000033. Epub 2021 Jun 02.

No abstract available.

Cite
Tufo-Pereyra A, Scatularo CE, Cardone F, et al. [Pericarditis por SARS-CoV-2: informe de caso]. Arch Cardiol Mex. 2021;doi: 10.24875/ACM.21000033.
Tufo-Pereyra, A., Scatularo, C. E., Cardone, F., & Grancelli, H. (2021). [Pericarditis por SARS-CoV-2: informe de caso]. Archivos de cardiologia de Mexico, . https://doi.org/10.24875/ACM.21000033
Tufo-Pereyra, Andrea, et al. "[Pericarditis por SARS-CoV-2: informe de caso]." Archivos de cardiologia de Mexico vol. (2021). doi: https://doi.org/10.24875/ACM.21000033
Tufo-Pereyra A, Scatularo CE, Cardone F, Grancelli H. [Pericarditis por SARS-CoV-2: informe de caso]. Arch Cardiol Mex. 2021 Jun 02; doi: 10.24875/ACM.21000033. Epub 2021 Jun 02. Spanish. PMID: 34077413.
Copy Download .nbib Format: NLM
Gas-containing renal stones: a red flag for renal infection.

Acta radiologica (Stockholm, Sweden : 1987)

Zawaideh JP, Simonato A, Barbero S, Bertolotto M, Cardone G, Vota P, Pavlica P, Derchi LE.
PMID: 34719244
Acta Radiol. 2021 Oct 30;2841851211052990. doi: 10.1177/02841851211052990. Epub 2021 Oct 30.

BACKGROUND: Gas in the renal excretory system is described as a consequence of recent procedures but it can be a sign of severe conditions such as fistulas or infections; however, gas-containing renal stones are only rarely encountered.PURPOSE: To describe...

Cite
Zawaideh JP, Simonato A, Barbero S, et al. Gas-containing renal stones: a red flag for renal infection. Acta Radiol. 2021;2841851211052990doi: 10.1177/02841851211052990.
Zawaideh, J. P., Simonato, A., Barbero, S., Bertolotto, M., Cardone, G., Vota, P., Pavlica, P., & Derchi, L. E. (2021). Gas-containing renal stones: a red flag for renal infection. Acta radiologica (Stockholm, Sweden : 1987), 2841851211052990. https://doi.org/10.1177/02841851211052990
Zawaideh, Jeries Paolo, et al. "Gas-containing renal stones: a red flag for renal infection." Acta radiologica (Stockholm, Sweden : 1987) vol. (2021): 2841851211052990. doi: https://doi.org/10.1177/02841851211052990
Zawaideh JP, Simonato A, Barbero S, Bertolotto M, Cardone G, Vota P, Pavlica P, Derchi LE. Gas-containing renal stones: a red flag for renal infection. Acta Radiol. 2021 Oct 30;2841851211052990. doi: 10.1177/02841851211052990. Epub 2021 Oct 30. PMID: 34719244.
Copy Download .nbib Format: NLM
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.

Leukemia

Marchesi F, Pimpinelli F, Giannarelli D, Ronchetti L, Papa E, Falcucci P, Pontone M, Di Domenico EG, di Martino S, Laquintana V, Mandoj C, Conti L, Cordone I, La Malfa A, Viggiani C, Renzi D, Palombi F, Romano A, Pisani F, Gumenyuk S, Di Bella O, Vujovic B, Morrone A, Ciliberto G, Ensoli F, Mengarelli A.
PMID: 34545184
Leukemia. 2021 Sep 20; doi: 10.1038/s41375-021-01418-8. Epub 2021 Sep 20.

No abstract available.

Cite
Marchesi F, Pimpinelli F, Giannarelli D, et al. Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas. Leukemia. 2021;doi: 10.1038/s41375-021-01418-8.
Marchesi, F., Pimpinelli, F., Giannarelli, D., Ronchetti, L., Papa, E., Falcucci, P., Pontone, M., Di Domenico, E. G., di Martino, S., Laquintana, V., Mandoj, C., Conti, L., Cordone, I., La Malfa, A., Viggiani, C., Renzi, D., Palombi, F., Romano, A., Pisani, F., Gumenyuk, S., Di Bella, O., Vujovic, B., Morrone, A., Ciliberto, G., Ensoli, F., & Mengarelli, A. (2021). Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas. Leukemia, . https://doi.org/10.1038/s41375-021-01418-8
Marchesi, Francesco, et al. "Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas." Leukemia vol. (2021). doi: https://doi.org/10.1038/s41375-021-01418-8
Marchesi F, Pimpinelli F, Giannarelli D, Ronchetti L, Papa E, Falcucci P, Pontone M, Di Domenico EG, di Martino S, Laquintana V, Mandoj C, Conti L, Cordone I, La Malfa A, Viggiani C, Renzi D, Palombi F, Romano A, Pisani F, Gumenyuk S, Di Bella O, Vujovic B, Morrone A, Ciliberto G, Ensoli F, Mengarelli A. Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas. Leukemia. 2021 Sep 20; doi: 10.1038/s41375-021-01418-8. Epub 2021 Sep 20. PMID: 34545184; PMCID: PMC8451738.
Copy Download .nbib Format: NLM
Integrated prevention and management of non-communicable diseases, including musculoskeletal health: a systematic policy analysis among OECD countries.

BMJ global health

Briggs AM, Persaud JG, Deverell ML, Bunzli S, Tampin B, Sumi Y, Amundsen O, Houlding EM, Cardone A, Hugosdottir T, Rogers S, Pozsgai M, Slater H.
PMID: 31565419
BMJ Glob Health. 2019 Sep 11;4(5):e001806. doi: 10.1136/bmjgh-2019-001806. eCollection 2019.

INTRODUCTION: Development and implementation of appropriate health policy is essential to address the rising global burden of non-communicable diseases (NCDs). The aim of this study was to evaluate existing health policies for integrated prevention/management of NCDs among Member States...

Cite
Briggs AM, Persaud JG, Deverell ML, et al. Integrated prevention and management of non-communicable diseases, including musculoskeletal health: a systematic policy analysis among OECD countries. BMJ Glob Health. 2019;4(5):e001806doi: 10.1136/bmjgh-2019-001806.
Briggs, A. M., Persaud, J. G., Deverell, M. L., Bunzli, S., Tampin, B., Sumi, Y., Amundsen, O., Houlding, E. M., Cardone, A., Hugosdottir, T., Rogers, S., Pozsgai, M., & Slater, H. (2019). Integrated prevention and management of non-communicable diseases, including musculoskeletal health: a systematic policy analysis among OECD countries. BMJ global health, 4(5), e001806. https://doi.org/10.1136/bmjgh-2019-001806
Briggs, Andrew M, et al. "Integrated prevention and management of non-communicable diseases, including musculoskeletal health: a systematic policy analysis among OECD countries." BMJ global health vol. 4,5 (2019): e001806. doi: https://doi.org/10.1136/bmjgh-2019-001806
Briggs AM, Persaud JG, Deverell ML, Bunzli S, Tampin B, Sumi Y, Amundsen O, Houlding EM, Cardone A, Hugosdottir T, Rogers S, Pozsgai M, Slater H. Integrated prevention and management of non-communicable diseases, including musculoskeletal health: a systematic policy analysis among OECD countries. BMJ Glob Health. 2019 Sep 11;4(5):e001806. doi: 10.1136/bmjgh-2019-001806. eCollection 2019. PMID: 31565419; PMCID: PMC6747900.
Copy Download .nbib Format: NLM
Complexity of Frontal Cortex fNIRS Can Support Alzheimer Disease Diagnosis in Memory and Visuo-Spatial Tests.

Entropy (Basel, Switzerland)

Perpetuini D, Chiarelli AM, Cardone D, Filippini C, Bucco R, Zito M, Merla A.
PMID: 33266742
Entropy (Basel). 2019 Jan 01;21(1). doi: 10.3390/e21010026.

Decline in visuo-spatial skills and memory failures are considered symptoms of Alzheimer's Disease (AD) and they can be assessed at early stages employing clinical tests. However, performance in a single test is generally not indicative of AD. Functional neuroimaging,...

Cite
Perpetuini D, Chiarelli AM, Cardone D, et al. Complexity of Frontal Cortex fNIRS Can Support Alzheimer Disease Diagnosis in Memory and Visuo-Spatial Tests. Entropy (Basel). 2019;21(1)doi: 10.3390/e21010026.
Perpetuini, D., Chiarelli, A. M., Cardone, D., Filippini, C., Bucco, R., Zito, M., & Merla, A. (2019). Complexity of Frontal Cortex fNIRS Can Support Alzheimer Disease Diagnosis in Memory and Visuo-Spatial Tests. Entropy (Basel, Switzerland), 21(1), . https://doi.org/10.3390/e21010026
Perpetuini, David, et al. "Complexity of Frontal Cortex fNIRS Can Support Alzheimer Disease Diagnosis in Memory and Visuo-Spatial Tests." Entropy (Basel, Switzerland) vol. 21,1 (2019). doi: https://doi.org/10.3390/e21010026
Perpetuini D, Chiarelli AM, Cardone D, Filippini C, Bucco R, Zito M, Merla A. Complexity of Frontal Cortex fNIRS Can Support Alzheimer Disease Diagnosis in Memory and Visuo-Spatial Tests. Entropy (Basel). 2019 Jan 01;21(1). doi: 10.3390/e21010026. PMID: 33266742; PMCID: PMC7514130.
Copy Download .nbib Format: NLM
The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation.

Frontiers in genetics

Mescoli A, Maffei G, Pillo G, Bortone G, Marchesi S, Morandi E, Ranzi A, Rotondo F, Serra S, Vaccari M, Zauli Sajani S, Mascolo MG, Jacobs MN, Colacci A.
PMID: 33240326
Front Genet. 2020 Nov 09;11:579964. doi: 10.3389/fgene.2020.579964. eCollection 2020.

As the novel coronavirus disease sweeps across the world, there is growing speculation on the role that atmospheric factors may have played on the different distribution of SARS-CoV-2, and on the epidemiological characteristics of COVID-19. Knowing the role that...

Cite
Mescoli A, Maffei G, Pillo G, et al. The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation. Front Genet. 2020;11:579964doi: 10.3389/fgene.2020.579964.
Mescoli, A., Maffei, G., Pillo, G., Bortone, G., Marchesi, S., Morandi, E., Ranzi, A., Rotondo, F., Serra, S., Vaccari, M., Zauli Sajani, S., Mascolo, M. G., Jacobs, M. N., & Colacci, A. (2020). The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation. Frontiers in genetics, 11579964. https://doi.org/10.3389/fgene.2020.579964
Mescoli, Ada, et al. "The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation." Frontiers in genetics vol. 11 (2020): 579964. doi: https://doi.org/10.3389/fgene.2020.579964
Mescoli A, Maffei G, Pillo G, Bortone G, Marchesi S, Morandi E, Ranzi A, Rotondo F, Serra S, Vaccari M, Zauli Sajani S, Mascolo MG, Jacobs MN, Colacci A. The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation. Front Genet. 2020 Nov 09;11:579964. doi: 10.3389/fgene.2020.579964. eCollection 2020. PMID: 33240326; PMCID: PMC7680895.
Copy Download .nbib Format: NLM
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.

Journal of translational medicine

Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C.
PMID: 34674735
J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9.

No abstract available.

Cite
Perrone F, Piccirillo MC, Ascierto PA, et al. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2021;19(1):442doi: 10.1186/s12967-021-03094-9.
Perrone, F., Piccirillo, M. C., Ascierto, P. A., Salvarani, C., Parrella, R., Marata, A. M., Popoli, P., Ferraris, L., Marrocco-Trischitta, M. M., Ripamonti, D., Binda, F., Bonfanti, P., Squillace, N., Castelli, F., Muiesan, M. L., Lichtner, M., Calzetti, C., Salerno, N. D., Atripaldi, L., Cascella, M., Costantini, M., Dolci, G., Facciolongo, N. C., Fraganza, F., Massari, M., Montesarchio, V., Mussini, C., Negri, E. A., Botti, G., Cardone, C., Gargiulo, P., Gravina, A., Schettino, C., Arenare, L., Chiodini, P., Gallo, C. (2021). Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. Journal of translational medicine, 19(1), 442. https://doi.org/10.1186/s12967-021-03094-9
Perrone, Francesco, et al. "Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial." Journal of translational medicine vol. 19,1 (2021): 442. doi: https://doi.org/10.1186/s12967-021-03094-9
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. PMID: 34674735; PMCID: PMC8529863.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 266 entries